Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1988 Jun;57(6):576–578. doi: 10.1038/bjc.1988.131

Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16.

M A Smith 1, S Merry 1, J G Smith 1, S B Kaye 1
PMCID: PMC2246452  PMID: 3408645

Full text

PDF
576

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benson A. B., 3rd, Trump D. L., Koeller J. M., Egorin M. I., Olman E. A., Witte R. S., Davis T. E., Tormey D. C. Phase I study of vinblastine and verapamil given by concurrent iv infusion. Cancer Treat Rep. 1985 Jul-Aug;69(7-8):795–799. [PubMed] [Google Scholar]
  2. Dowsett M., Harris A. L., Stuart-Harris R., Hill M., Cantwell B. M., Smith I. E., Jeffcoate S. L. A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients. Br J Cancer. 1985 Oct;52(4):525–529. doi: 10.1038/bjc.1985.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fine R. L., Koizumi S., Curt G. A., Chabner B. A. Effect of calcium channel blockers on human CFU-GM with cytotoxic drugs. J Clin Oncol. 1987 Mar;5(3):489–495. doi: 10.1200/JCO.1987.5.3.489. [DOI] [PubMed] [Google Scholar]
  4. Ikeda H., Nakano G., Nagashima K., Sakamoto K., Harasawa N., Kitamura T., Nakamura T., Nagamachi Y. Verapamil enhancement of antitumor effect of cis-diamminedichloroplatinum(II) in nude mouse-grown human neuroblastoma. Cancer Res. 1987 Jan 1;47(1):231–234. [PubMed] [Google Scholar]
  5. Mattern J., Bak M., Volm M. Occurrence of a multidrug-resistant phenotype in human lung xenografts. Br J Cancer. 1987 Oct;56(4):407–411. doi: 10.1038/bjc.1987.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Merry S., Courtney E. R., Fetherston C. A., Kaye S. B., Freshney R. I. Circumvention of drug resistance in human non-small cell lung cancer in vitro by verapamil. Br J Cancer. 1987 Oct;56(4):401–405. doi: 10.1038/bjc.1987.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Merry S., Fetherston C. A., Kaye S. B., Freshney R. I., Plumb J. A. Resistance of human glioma to adriamycin in vitro: the role of membrane transport and its circumvention with verapamil. Br J Cancer. 1986 Jan;53(1):129–135. doi: 10.1038/bjc.1986.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ramu A., Spanier R., Rahamimoff H., Fuks Z. Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells. Br J Cancer. 1984 Oct;50(4):501–507. doi: 10.1038/bjc.1984.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Robinson B. A., Clutterbuck R. D., Millar J. L., McElwain T. J. Verapamil potentiation of melphalan cytotoxicity and cellular uptake in murine fibrosarcoma and bone marrow. Br J Cancer. 1985 Dec;52(6):813–822. doi: 10.1038/bjc.1985.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rogan A. M., Hamilton T. C., Young R. C., Klecker R. W., Jr, Ozols R. F. Reversal of adriamycin resistance by verapamil in human ovarian cancer. Science. 1984 Jun 1;224(4652):994–996. doi: 10.1126/science.6372095. [DOI] [PubMed] [Google Scholar]
  11. Simmonds A. P., Moyes P., Nicol A., Davidson K. G., Faichney A. Enhancement of cytotoxicity of vindesine and cis-platinum for human lung tumours by the use of verapamil in vitro. Br J Cancer. 1986 Dec;54(6):1015–1018. doi: 10.1038/bjc.1986.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Slater L. M., Murray S. L., Wetzel M. W., Sweet P., Stupecky M. Verapamil potentiation of VP-16-213 in acute lymphatic leukemia and reversal of pleiotropic drug resistance. Cancer Chemother Pharmacol. 1986;16(1):50–54. doi: 10.1007/BF00255285. [DOI] [PubMed] [Google Scholar]
  13. Slater L. M., Murray S. L., Wetzel M. W., Wisdom R. M., DuVall E. M. Verapamil restoration of daunorubicin responsiveness in daunorubicin-resistant Ehrlich ascites carcinoma. J Clin Invest. 1982 Nov;70(5):1131–1134. doi: 10.1172/JCI110702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Supino R., Prosperi E., Formelli F., Mariani M., Parmiani G. Characterization of a doxorubicin-resistant murine melanoma line: studies on cross-resistance and its circumvention. Br J Cancer. 1986 Jul;54(1):33–42. doi: 10.1038/bjc.1986.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Tsuruo T., Iida H., Naganuma K., Tsukagoshi S., Sakurai Y. Promotion by verapamil of vincristine responsiveness in tumor cell lines inherently resistant to the drug. Cancer Res. 1983 Feb;43(2):808–813. [PubMed] [Google Scholar]
  16. Tsuruo T., Iida H., Tsukagoshi S., Sakurai Y. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res. 1982 Nov;42(11):4730–4733. [PubMed] [Google Scholar]
  17. Tsuruo T., Iida H., Tsukagoshi S., Sakurai Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 1981 May;41(5):1967–1972. [PubMed] [Google Scholar]
  18. Tsuruo T., Iida H., Tsukagoshi S., Sakurai Y. Potentiation of vincristine and Adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors. Cancer Res. 1983 May;43(5):2267–2272. [PubMed] [Google Scholar]
  19. Twentyman P. R., Fox N. E., Wright K. A., Bleehen N. M. Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells. Br J Cancer. 1986 Apr;53(4):529–537. doi: 10.1038/bjc.1986.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Yalowich J. C., Ross W. E. Potentiation of etoposide-induced DNA damage by calcium antagonists in L1210 cells in vitro. Cancer Res. 1984 Aug;44(8):3360–3365. [PubMed] [Google Scholar]
  21. Yalowich J. C., Zucali J. R., Gross M., Ross W. E. Effects of verapamil on etoposide, vincristine, and adriamycin activity in normal human bone marrow granulocyte-macrophage progenitors and in human K562 leukemia cells in vitro. Cancer Res. 1985 Oct;45(10):4921–4924. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES